do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation Frontiers | for treating T2DM DPP-4 and GLP-1 Combination: Safety

Understanding the facts can help you make an informed decision

Furthermore, at 10 M concentration, BAPN would exclusively inhibit lysyl oxidases (IC 50 (LOX) = 5 M), whereas Semicarbazide-sensitive amine oxidase (SSAO) would not be affected at this concentration (IC 50 = 4 mM) 45

It also warned that patients should be asked about whether they are taking GLP-1 or dual GIP/GLP-1 RAs, as there is a possibility that patients may have purchased GLP-1 or dual GIP/GLP-1 RAs for aesthetic weight loss and may not readily disclose this information unless directly asked

The activation of these receptors work collectively with no effect on the rest of the bodys hormones

Your diabetes care team will need to adjust your treatment plan accordingly